PT Kalbe Farma Tbk. Statistics

Total Valuation

PT Kalbe Farma Tbk. has a market cap or net worth of IDR 58.84 trillion. The enterprise value is 57.00 trillion.

Market Cap	58.84T
Enterprise Value	57.00T

Important Dates

The next estimated earnings date is Friday, February 14, 2025.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	n/a

Share Statistics

PT Kalbe Farma Tbk. has 46.15 billion shares outstanding. The number of shares has decreased by -0.86% in one year.

Current Share Class	n/a
Shares Outstanding	46.15B
Shares Change (YoY)	-0.86%
Shares Change (QoQ)	-0.48%
Owned by Insiders (%)	0.25%
Owned by Institutions (%)	13.33%
Float	18.85B

Valuation Ratios

The trailing PE ratio is 19.09 and the forward PE ratio is 17.49. PT Kalbe Farma Tbk.'s PEG ratio is 1.41.

PE Ratio	19.09
Forward PE	17.49
PS Ratio	1.83
PB Ratio	2.65
P/TBV Ratio	2.94
P/FCF Ratio	14.73
P/OCF Ratio	n/a
PEG Ratio	1.41

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.03, with an EV/FCF ratio of 14.27.

EV / Earnings	18.50
EV / Sales	1.77
EV / EBITDA	12.03
EV / EBIT	14.22
EV / FCF	14.27

Financial Position

The company has a current ratio of 4.15, with a Debt / Equity ratio of 0.03.

Current Ratio	4.15
Quick Ratio	2.32
Debt / Equity	0.03
Debt / EBITDA	0.16
Debt / FCF	0.19
Interest Coverage	70.91

Financial Efficiency

Return on equity (ROE) is 13.40% and return on invested capital (ROIC) is 10.36%.

Return on Equity (ROE)	13.40%
Return on Assets (ROA)	8.92%
Return on Capital (ROIC)	10.36%
Revenue Per Employee	2.49B
Profits Per Employee	238.33M
Employee Count	13,108
Asset Turnover	1.15
Inventory Turnover	2.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.19% in the last 52 weeks. The beta is 0.21, so PT Kalbe Farma Tbk.'s price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	-23.19%
50-Day Moving Average	1,534.90
200-Day Moving Average	1,559.50
Relative Strength Index (RSI)	21.61
Average Volume (20 Days)	44,460,270

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Kalbe Farma Tbk. had revenue of IDR 32.13 trillion and earned 3.08 trillion in profits. Earnings per share was 66.79.

Revenue	32.13T
Gross Profit	12.21T
Operating Income	3.99T
Pretax Income	4.08T
Net Income	3.08T
EBITDA	4.67T
EBIT	3.99T
Earnings Per Share (EPS)	66.79

Full Income Statement

Balance Sheet

The company has 4.32 trillion in cash and 743.45 billion in debt, giving a net cash position of 3.57 trillion or 77.42 per share.

Cash & Cash Equivalents	4.32T
Total Debt	743.45B
Net Cash	3.57T
Net Cash Per Share	77.42
Equity (Book Value)	23.91T
Book Value Per Share	480.69
Working Capital	12.93T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.96 trillion and capital expenditures -962.19 billion, giving a free cash flow of 3.99 trillion.

Operating Cash Flow	4.96T
Capital Expenditures	-962.19B
Free Cash Flow	3.99T
FCF Per Share	86.54

Full Cash Flow Statement

Margins

Gross margin is 38.02%, with operating and profit margins of 12.42% and 9.59%.

Gross Margin	38.02%
Operating Margin	12.42%
Pretax Margin	12.71%
Profit Margin	9.59%
EBITDA Margin	14.54%
EBIT Margin	12.42%
FCF Margin	12.43%

Dividends & Yields

This stock pays an annual dividend of 31.00, which amounts to a dividend yield of 2.43%.

Dividend Per Share	31.00
Dividend Yield	2.43%
Dividend Growth (YoY)	-18.42%
Years of Dividend Growth	3
Payout Ratio	46.55%
Buyback Yield	0.86%
Shareholder Yield	3.29%
Earnings Yield	5.24%
FCF Yield	6.79%

Dividend Details

Stock Splits

The last stock split was on October 8, 2012. It was a forward split with a ratio of 5.

Last Split Date	Oct 8, 2012
Split Type	Forward
Split Ratio	5

Scores

PT Kalbe Farma Tbk. has an Altman Z-Score of 12.31.

Altman Z-Score	12.31
Piotroski F-Score	n/a